Detalhe da pesquisa
1.
Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.
Clin Infect Dis
; 69(8): 1320-1328, 2019 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30590412
2.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
PLoS One
; 15(9): e0238575, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941476
3.
A Longitudinal Analysis Reveals Early Activation and Late Alterations in B Cells During Primary HIV Infection in Mozambican Adults.
Front Immunol
; 11: 614319, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33519823
4.
Extremely low viral reservoir in treated chronically HIV-1-infected individuals.
EBioMedicine
; 57: 102830, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580136
5.
Estado actual de los tratamientos para la COVID-19.
FMC
; 28(1): 40-56, 2021 Jan.
Artigo
em Espanhol
| MEDLINE | ID: mdl-33519178